Association of early suspected acute exacerbations of idiopathic pulmonary fibrosis with subsequent clinical outcomes and healthcare resource utilization

Respiratory Medicine

Volumn 109, Issue 12, 2015, Pages 1582-1588

  Yu, Yanni F ^a   Macaulay, Dendy S ^b   Reichmann, William M ^b   Wu, Eric Q ^b   Nathan, Steven D ^c  

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^b ANALYSIS GROUP   (United States)

^c INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

Acute exacerbations; FVC; Healthcare resource use; Idiopathic pulmonary fibrosis; Lung function; Mortality

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; EMERGENCY WARD; FEMALE; FIBROSING ALVEOLITIS; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; LUNG BIOPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OUTCOME ASSESSMENT; OUTPATIENT; PHYSICIAN; PRIORITY JOURNAL; PULMONOLOGIST; UNITED STATES; ACUTE DISEASE; AGE DISTRIBUTION; AMBULATORY CARE; CLINICAL TRIAL; EARLY DIAGNOSIS; EPIDEMIOLOGY; FORCED EXPIRATORY VOLUME; HEALTH CARE PLANNING; IDIOPATHIC PULMONARY FIBROSIS; INTENSIVE CARE; LENGTH OF STAY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PATIENT ATTITUDE; PHYSIOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UTILIZATION; VITAL CAPACITY;

ACUTE DISEASE; AGE DISTRIBUTION; AMBULATORY CARE; CRITICAL CARE; EARLY DIAGNOSIS; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH RESOURCES; HOSPITALIZATION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PROGNOSIS; RETROSPECTIVE STUDIES; UNITED STATES; VITAL CAPACITY;

EID: 84951574057     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2015.11.001     Document Type: Article

References (15)

1. G. Raghu, H.R. Collard, J.J. Egan, F.J. Martinez, J. Behr, K.K. Brown, and et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am. J. Respir. Crit. Care Med. 183 2011 788 824 10.1164/rccm.2009-040GL
2. H.R. Collard, B.B. Moore, K.R. Flaherty, K.K. Brown, R.J. Kaner, T.E. King, and et al. Acute exacerbations of idiopathic pulmonary fibrosis Am. J. Respir. Crit. Care Med. 176 2007 636 643 10.1164/rccm.200703-463PP
3. D.S. Kim Acute exacerbation of idiopathic pulmonary fibrosis Clin. Chest Med. 33 2012 59 68 10.1016/j.ccm.2012.01.001
4. D.S. Kim Acute exacerbations in patients with idiopathic pulmonary fibrosis Respir. Res. 14 2013 86 10.1186/1465-9921-14-86
5. R. Hyzy, S. Huang, J. Myers, K. Flaherty, and F. Martinez Acute exacerbation of idiopathic pulmonary fibrosis Chest 132 2007 1652 1658 10.1378/chest.07-0299
6. Y. Kondoh, H. Taniguchi, T. Katsuta, K. Kataoka, T. Kimura, O. Nishiyama, and et al. Risk factors of acute exacerbation of idiopathic pulmonary fibrosis Sarcoidosis Vasc. Diffus. Lung Dis. 27 2010 103 110
7. J.W. Song, S.-B. Hong, C.-M. Lim, Y. Koh, and D.S. Kim Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome Eur. Respir. J. 37 2011 356 363 10.1183/09031936.00159709
8. H. Kubo, K. Nakayama, M. Yanai, T. Suzuki, M. Yamaya, M. Watanabe, and et al. Anticoagulant therapy for idiopathic pulmonary fibrosis Chest 128 2005 1475 1482 10.1378/chest.128.3.1475
9. C.E. Daniels, E.S. Yi, and J.H. Ryu Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis Eur. Respir. J. 32 2008 170 174 10.1183/09031936.00176307
10. V. Simon-Blancal, O. Freynet, H. Nunes, D. Bouvry, N. Naggara, P.-Y. Brillet, and et al. Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors Respir. Int. Rev. Thorac. Dis. 83 2012 28 35 10.1159/000329891
11. AMA Master List of Pulmonologists 2013
12. S.D. Nathan, W.M. Reichmann, D. Macaulay, and Y.F. Yu Change in Forced Vital Capacity and Clinical Outcomes in Newly Diagnosed Idiopathic Pulmonary Fibrosis Patients 2015 American Thoracic Society Denver, CO
13. W. Reichmann, Y. Yu, D. Macaulay, and S. Nathan Association of Change in Forced Vital Capacity with Healthcare Resource Utilization in Patients with Newly Diagnosed Idiopathic Pulmonary Fibrosis 2015 International Society for Pharmacoeconomics and Outcomes Research Philadelphia, PA
14. L. Richeldi, R.M. du Bois, G. Raghu, A. Azuma, K.K. Brown, U. Costabel, and et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis N. Engl. J. Med. 370 2014 2071 2082 10.1056/NEJMoa1402584
15. H.R. Collard, E. Yow, L. Richeldi, K.J. Anstrom, and C. Glazer IPFnet investigators. Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials Respir. Res. 14 2013 73 10.1186/1465-9921-14-73